Progression of cardiovascular autonomic dysfunction in patients with type 2 diabetes A 7-year follow-up study

Diabetes Care

Volumn 31, Issue 9, 2008, Pages 1832-1836

  Ko, Seung Hyun ^a   Park, Shin Ae ^a   Cho, Jae Hyoung ^a   Song, Ki Ho ^a   Yoon, Kun Ho ^a   Cha, Bong Yun ^a   Son, Ho Young ^a   Yoo, Ki Dong ^a   Moon, Keon Woong ^a   Park, Yong Moon ^a   Ahn, Yu Bai ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C;

ADULT; AGED; ARTICLE; AUTONOMIC DYSFUNCTION; AUTONOMIC NERVE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIABETIC RETINOPATHY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE DURATION; FEMALE; FOLLOW UP; GLYCEMIC CONTROL; HEART RATE VARIABILITY; HUMAN; HYPERTENSION; LOGISTIC REGRESSION ANALYSIS; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; OBSERVATIONAL STUDY; SCORING SYSTEM; STANDING; VALSALVA MANEUVER; BODY POSTURE; DIABETIC ANGIOPATHY; DIABETIC NEUROPATHY; GLUCOSE BLOOD LEVEL; HEART RATE; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; REGRESSION ANALYSIS; TIME;

ADULT; BLOOD GLUCOSE; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; DIABETIC NEUROPATHIES; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HEART RATE; HUMANS; MALE; MIDDLE AGED; POSTURE; REGRESSION ANALYSIS; TIME FACTORS; VALSALVA MANEUVER;

EID: 56149114787     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc08-0682     Document Type: Article

References (25)

1. Goff DC Jr, Gerstein HC, Ginsberg HN, Cushman WC, Margolis KL, Byington RP, Buse JB, Genuth S, Probstfield JL, Simons-Morton DG, ACCORD Study Group: Prevention of cardiovascular disease in persons with type 2 diabetes mellitus: current knowledge and rationale for the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. Am J Cardiol 18:4i-20i, 2007
2. Vinik AI, Maser RE, Mitchell BD, Freeman R: Diabetic autonomic neuropathy. Diabetes Care 26:1553-1579, 2003
3. 3.Wheeler SG, Ahroni JH, Boyko EJ: Prospective study of autonomic neuropathy as a predictor of mortality in patients with diabetes. Diabetes Res Clin Pract 58:131-138, 2002
4. Maser RE, Mitchell BD, Vinik AI, Freeman R: The association between cardiovascular autonomic neuropathy and mortality in individuals with diabetes: a meta-anal-ysis. Diabetes Care 26:1895-1901, 2003
5. Vinik AI, Ziegler D: Diabetic cardiovascular autonomic neuropathy. Circulation 115:387-397, 2007
6. Ewing DJ, Martyn CN, Young RJ, Clarke BF: The value of cardiovascular auto-nomic function tests: 10 years experience in diabetes. Diabetes Care 8:491-498, 1985
7. Ziegler D, Gries FA, Spuler M, Lessmann F: The epidemiology of diabetic neuropathy: Diabetic Cardiovascular Autonomic Neuropathy Multicenter Study Group. J Diabetes Complications 6:49-57, 1992
8. Kennedy WR, Navarro X, Sutherland DE: Neuropathy profile of diabetic patients in a pancreas transplantation program. Neurology 45:773-780, 1995
9. Stratton IM, Adler AI, Neil HA, Matthews DR, Manley SE, Cull CA, Hadden D, Turner RC, Holman RR: Association of glycaemia with macrovascular and micro-vascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 12:405-412, 2000
10. The Diabetes Control and Complication Trial Research Group: The effect of intensive diabetes therapy on the development and progression of neuropathy. Ann In-ternMed 122:561-568, 1995
11. Tesfaye S, Chaturvedi N, Eaton SE, Ward JD, Manes C, Ionescu-Tirgoviste C, Witte DR, Fuller JH: EURODIAB Prospective Complications Study Group: Vascular risk factors and diabetic neuropathy. N Engl J Med 352:341-350, 2005
12. Ziegler D: Diabetic cardiovascular auto-nomic neuropathy: prognosis, diagnosis and treatment. Diabetes Metab Rev 10: 339-383, 1994
13. Young RJ, Ewing DJ, Clarke BF: Nerve function and metabolic control in teenage diabetics. Diabetes 32:142-147, 1983
14. Boulton AJ, Vinik AI, Arezzo JC, Bril V, Feldman EL, Freeman R, Malik RA, Maser RE, Sosenko JM, Ziegler D, American Diabetes Association. Diabetic neuropathies: a statement by the American Diabetes Association. Diabetes Care 28:956-962, 2005
15. Kearney EM, Mount JN, Watts GF, Slavin BM, Kind P: Simple immunoturbidimet-ric method for determining urinary albumin at low concentrations using Cobas-Bio centrifugal analyser. J Clin Pathol 40:465-468, 1987
16. Selvin E, Marinopoulos S, Berkenblit G, Rami T, Brancati FL, Powe NR, Golden SH: Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus. Ann Intern Med 141:421-431, 2004
17. Stevens RJ, Coleman RL, Adler AI, Strat-ton IM, Matthews DR, Holman RR: Risk factors for myocardial infarction case fatality and stroke case fatality in type 2 diabetes: UKPDS 66. Diabetes Care 27:201-207, 2004
18. Jermendy G: Clinical consequences of cardiovascular autonomic neuropathy in diabetic patients. Acta Diabetol 40 (Suppl. 2):S370-S374, 2003
19. Maser RE, Lenhard MJ: Cardiovascular autonomic neuropathy due to diabetes mellitus: clinical manifestations, consequences, and treatment. JClin Endocrinol Metab 90:5896-5903, 2005
20. Ziegler D, Laux G, Dannehl K, Spuler M, Muhlen H, Mayer P, Gries FA: Assessment of cardiovascular autonomic function: age-related normal ranges and reproduc-ibility of spectral analysis, vector analysis, and standard tests of heart rate variation and blood pressure responses. Diabet Med 9:166-175, 1992
21. Dyrberg T, Benn J, Christiansen JS, Hilsted J, Nerup J: Prevalence of diabetic autonomic neuropathy measured by simple bedside tests. Diabetologia 20:190-194, 1981
22. Mackay JD, Page MM, Cambridge J, Watkins PJ: Diabetic autonomic neuropathy: the diagnostic value of heart rate monitoring. Diabetologia 18:471-478, 1980
23. The effect of intensive diabetes therapy on measures of autonomic nervous system function in the Diabetes Control and Complications Trial (DCCT). Diabetologia 41:416-423, 1998
24. Valensi P, Paries J, Attali JR, French Group for Research and Study of Diabetic Neuropathy: Cardiac autonomic neuropathy in diabetic patients: influence of diabetes duration, obesity, and microangiopathic complications-the French multicenter study. Metabolism 52:815-820, 2003
25. Takahashi N, Anan F, Nakagawa M, Yufu K, Ooie T, Nawata T, Shigematsu S, Hara M, Saikawa T, Yoshimatsu H: Microalbumin-uria, cardiovascular autonomic dysfunction, and insulin resistance in patients with type 2 diabetes mellitus. Metabolism 53:1359-1364, 2004